Key result
Intrapericardial triamcinolone plus low-dose chemotherapy controls refractory malignant pericardial effusion in primary cardiac lymphoma.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Conservative management of primary cardiac lymphoma combining systemic chemotherapy with intrapericardial triamcinolone can effectively control refractory malignant pericardial effusion and avoid high-risk surgical procedures in frail patients.
Primary cardiac lymphoma is a rare cause of pericardial effusion and tamponade that can present without a solid mass. An 85-year-old frail man with ischemic cardiomyopathy presented with tamponade from an isolated, rapidly enlarging hemorrhagic pericardial effusion. Fluid cytology and positron emission tomography-computed tomography confirmed human herpesvirus 8-negative, effusion-based large B-cell lymphoma. Given his high surgical risk and comorbidities, a tissue biopsy was avoided. He was managed with low-dose palliative chemotherapy and adjunctive intrapericardial triamcinolone, which successfully halted persistent high-output drain output, allowing safe pericardial drain removal and pericardial effusion control without invasive surgery. This case demonstrates that effusion-based lymphomas can occur without mass lesions or overt immunosuppression. It highlights the utility of fluid cytology over invasive biopsy in frail patients, and showcases intrapericardial steroids as a conservative tool to control refractory malignant drain output. Conservative management of primary cardiac lymphoma combining systemic chemotherapy with intrapericardial steroids may help delay or avoid high-risk surgical procedures in frail patients.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) conducted a case report in Primary cardiac lymphoma (human herpesvirus 8-negative, effusion-based large B-cell lymphoma) presenting with recurrent pericardial effusion and tamponade (n=1). Low-dose palliative chemotherapy and adjunctive intrapericardial triamcinolone was evaluated on Control of persistent high-output pericardial drain output and pericardial effusion. Low-dose palliative chemotherapy plus intrapericardial triamcinolone controlled refractory malignant pericardial effusion in an 85-year-old man with primary cardiac lymphoma, avoiding surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: